Human Dermatopontin Antibody Summary
Accession # AAH33736
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Detection of Human Dermatopontin by Western Blot. Western blot shows lysates of human heart tissue. PVDF Membrane was probed with 1 µg/mL of Human Dermatopontin Antigen Affinity-purified Polyclonal Antibody (Catalog # AF4629) followed by HRP-conjugated Anti-Sheep IgG Secondary Antibody (Catalog # HAF016). A specific band was detected for Dermatopontin at approximately 22 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 8.
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Dermatopontin, also known as TRAMP (tyrosine rich acidic matrix protein), is a widely expressed noncollagenous protein component of the extracellular matrix (1, 2). Mature human Dermatopontin shares 96%, 92%, and 92% amino acid sequence identity with bovine, mouse, and rat Dermatopontin, respectively. It is a 22 kDa molecule that is tyrosine sulfated but not glycosylated (3, 4). Dermatopontin contains three disulfide bonded loop structures that enclose conserved hexapeptide motifs (5). It accelerates collagen fibril formation in vitro, and Dermatopontin deficient mice exhibit altered collagen matrix deposition and organization (6 - 8). Dermatopontin is downregulated in fibrotic growths such as leiomyoma and scar tissue (9, 10). It binds both TGF-beta and the proteoglycan decorin, interactions that can increase the bioavailability of TGF-beta (11, 12). Dermatopontin promotes bone mineralization under the control of the vitamin D receptor and inhibits BMP-2 effects on osteoblast precursors (13, 14).
- Okamoto, O. and S. Fujiwara (2006) Connect. Tissue Res. 47:177.
- Superti-Furga, A. et al. (1993) Genomics 17:463.
- Forbes, E.G. et al. (1994) FEBS Lett. 351:433.
- Cronshaw, A.D. et al. (1993) Matrix 13:255.
- Neame, P.J. et al. (1989) J. Biol. Chem. 264:5474.
- MacBeath, J.R.E. et al. (1993) J. Biol. Chem. 268:19826.
- Takeda, U. et al. (2002) J. Invest. Dermatol. 119:678.
- Cooper, L.J. et al. (2006) Invest. Opthalmol. Vis. Sci. 47:3303.
- Catherino, W.H. et al. (2004) Genes Chromosomes Cancer 40:204.
- Kuroda, K. et al. (1999) J. Invest. Dermatol. 112:706.
- Okamoto, O. et al. (1996) J. Biochem. 119:106.
- Okamoto, O. et al. (1999) Biochem. J. 337:537.
- Pochampally, R.R. et al. (2007) J. Bone Miner. Res. 22:1338.
- Behnam, K. et al. (2006) Connect. Tissue Res. 47:271.
No product specific FAQs exist for this product, however you mayView all Antibody FAQs
Reviews for Human Dermatopontin Antibody
There are currently no reviews for this product. Be the first to review Human Dermatopontin Antibody and earn rewards!
Have you used Human Dermatopontin Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image